Table 1 Clinical characteristics of participans according to BMI categories
Variable | Normal BMI 18.5–24.9 | Pre-obese BMI 25–29.9 | Class I and II obese BMI 30–39.9 | Class IIII obese BMI ≥40 | P |
|---|---|---|---|---|---|
N = 66 (19.5%) | N = 131 (38.8%) | N = 111 (32.9%) | N = 29 (8.6%) | ||
Age (mean, SD) | 62.4 (7.5) | 68.3 (6.9) | 69.8 (6.9) | 62.7 (9.9) | < 0.01 |
FIGO | 0.041 | ||||
I | 57 (86.3%) | 119 (90.8%) | 105 (94.5%) | 26 (89.6%) | |
II | 6 (9%) | 7 (5.3%) | 2 (1.8%) | 2 (6.8%) | |
III-IV | 3 (4.5%) | 5 (3.8%) | 4 (3.6%) | 1 (3.4%) | |
Grade | 0.852 | ||||
I | 36 (54.5%) | 69 (52.6%) | 54 (48.6%) | 18 (62%) | |
II | 25 (37.8%) | 54 (41.2%) | 50 (45%) | 9 (31%) | |
III | 5 (7.5%) | 8 (6.1%) | 7 (6.3%) | 2 (6.8%) | |
Treatment | |||||
Surgery without LYA | 55 (83.3%) | 103 (78.6%) | 81 (72.9%) | 28 (96.5%) | |
Surgery + LYA | 18 (27.2%) | 38 (29%) | 31 (27.9%) | 2 (6.8%) | 0.041 |
Surgery + RT | 13 (19.6%) | 29 (22.1%) | 22 (19.8%) | 2 (6.8%) | 0.374 |
Recurrence | 0.461 | ||||
Yes | 5 (7.5%) | 14 (10.6%) | 11 (9.9%) | 2 (6.8%) | |
No | 61 (92.4%) | 117 (89.3%) | 100 (90%) | 27 (93.1%) | |
Time since diagnosis | 0.897 | ||||
< 1 year | 5 (7.5%) | 10 (7.6%) | 10 (9%) | 3 (10.3%) | |
1–2 years | 7 (10.6%) | 19 (14.5%) | 16 (14.4%) | 4 (13.7%) | |
2–3 years | 12 (18.1%) | 22 (16.7%) | 21 (18.8%) | 5 (17.2%) | |
3–4 years | 13 (19.6%) | 25 (19%) | 23 (20.7%) | 6 (20.6%) | |
4–5 years | 12 (18.1%) | 23 (17.5%) | 17 (15.3%) | 6 (20.6%) | |
> 5 years | 17 (25.7%) | 32 (24.4%) | 24 (21.6%) | 5 (17.2%) | |
Comorbidity | |||||
No | 48 (72.7%) | 30 (22.9%) | 14 (12.6%) | 3 (10.3%) | |
Yes | 18 (27.2%) | 101 (77%) | 97 (87.3%) | 26 (89.6%) | < 0.01 |
Type of comorbidities | |||||
Diabetes | 6 (9%) | 18 (13.7%) | 31 (27.9%) | 14 (48.2%) | < 0.01 |
Hypertension | 15 (22.7%) | 63 (48%) | 68 (61.2%) | 21 (72.4%) | < 0.01 |
Arthrosis | 11 (16.6%) | 45 (34.3%) | 57 (51.3%) | 20 (68.9%) | < 0.01 |